- Home
- PRKS vs PTGX Comparison
PRKS vs PTGX Comparison
Compare PRKS & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRKS
- PTGX
- Stock Information
- Founded
- PRKS 1959
- PTGX 2006
- Country
- PRKS United States
- PTGX United States
- Employees
- PRKS N/A
- PTGX N/A
- Industry
- PRKS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- PRKS Health Care
- PTGX Health Care
- Exchange
- PRKS Nasdaq
- PTGX Nasdaq
- Market Cap
- PRKS 2.8B
- PTGX 3.3B
- IPO Year
- PRKS 2013
- PTGX 2016
- Fundamental
- Price
- PRKS $46.63
- PTGX $53.83
- Analyst Decision
- PRKS Buy
- PTGX Strong Buy
- Analyst Count
- PRKS 13
- PTGX 8
- Target Price
- PRKS $57.38
- PTGX $69.13
- AVG Volume (30 Days)
- PRKS 686.7K
- PTGX 665.9K
- Earning Date
- PRKS 08-07-2025
- PTGX 08-12-2025
- Dividend Yield
- PRKS N/A
- PTGX N/A
- EPS Growth
- PRKS 3.53
- PTGX N/A
- EPS
- PRKS 3.85
- PTGX 0.86
- Revenue
- PRKS $1,714,827,000.00
- PTGX $207,801,000.00
- Revenue This Year
- PRKS $2.13
- PTGX N/A
- Revenue Next Year
- PRKS $2.33
- PTGX $53.09
- P/E Ratio
- PRKS $12.11
- PTGX $62.41
- Revenue Growth
- PRKS N/A
- PTGX N/A
- 52 Week Low
- PRKS $37.68
- PTGX $32.50
- 52 Week High
- PRKS $60.83
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- PRKS 43.17
- PTGX 49.46
- Support Level
- PRKS $45.74
- PTGX $53.06
- Resistance Level
- PRKS $54.13
- PTGX $57.15
- Average True Range (ATR)
- PRKS 1.58
- PTGX 1.76
- MACD
- PRKS -0.42
- PTGX -0.22
- Stochastic Oscillator
- PRKS 11.71
- PTGX 36.89
About PRKS United Parks & Resorts Inc. Common Stock
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.